Journals / Klinik Tıp Aile Hekimliği / 2019 / Cilt: 11 - Sayı: 2

Reflux Laryngıtıs: Dıagnosıs and Treatment

Reflü Larenjit: Tanıve Tedavi

Pages
71–76
Publication Date
2019-03-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients who developed severe complications or have to use continuous PPI, ifthey have revealed pathological reflux, laparoscopic anti-reflux surgery is a promisingmethod in selected patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractReflux disease is defined as retrograde movement of the gastric content that causesign and/or symptoms which affecting the quality of life.
📊
Key Findings & Data:There is no reliable test defined as ‘gold standard’ for a definitive diagnosis of this very prevalent disease.
💡
Conclusion & Impact:In patients who developed severe complications or have to use continuous PPI, ifthey have revealed pathological reflux, laparoscopic anti-reflux surgery is a promisingmethod in selected patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Reflü · Reflü Larenjit · Larengofarengeal reflü

Abstract

AbstractReflux disease is defined as retrograde movement of the gastric content that causesign and/or symptoms which affecting the quality of life. There is no reliable test defined as ‘gold standard’ for a definitive diagnosis of this very prevalent disease. The mostreliable diagnostic method for reflux laryngitis is remission of symptoms and signs bylifestyle changes and anti-reflux treatment.Laryngeal mucosa, is more sensitive to acid than the esophagus. Thus a smaller amount and shorter exposure consists cell damage. Therefore reflux laryngitis therapy should be more aggressive and longer. Reflux laryngitis symptoms respond to treatment welland recovery occurs quickly. But physical examination findings heals in long-term. Non-healing patients who have revealed pathological reflux with monitoring under treatment,high-dose or super high-dose PPI therapy provides better results. In patients who developed severe complications or have to use continuous PPI, ifthey have revealed pathological reflux, laparoscopic anti-reflux surgery is a promisingmethod in selected patients.

Özet

ÖzGastrik içeriğin retrograd hareketi ile kişinin yaşam kalitesini etkileyen semptomve/veya bulgulara yol açması reflü hastalığı olarak tanımlanmaktadır. Çok yaygın görüldüğü kabul edilen bu hastalığın kesin tanısı için güvenilir altın standart bir test bulunmamaktadır. Reflü larenjitin en güvenilir tanı yöntemi, değiştirilen yaşam şekli ve anti-reflü tedavi ile semptom ve bulgularda gerileme olmasıdır. Larenks mukozası,aside özefagustan daha duyarlıdır. Dolayısıyla daha az miktarda ve daha kısa süreli maruziyet ile hücre hasarı oluşmaktadır. Bu nedenle reflü larenjit daha agresif ve dahauzun süreli tedavi edilmelidir. Reflü larenjit semptomları tedaviye çok iyi cevap verir ve çabuk düzelir. Ancak bulguların iyileşmesi zaman alır. Tedaviye cevap vermeyen hastalarda, tedavi altında yapılan monitorizasyon ile patolojik reflü ortaya konulmuşsa, yüksek doz veya süper yüksek doz proton pompa inhibitörü (PPİ) tedavisi yarar sağlar. Patolojik reflüsü ortaya konulmuş, devamlı PPİ kullanmak zorunda olan veyaciddi komplikasyon gelişmiş hastalarda laparoskopik anti-reflü cerrahi seçilmiş hastalarda gelecek vaat eden bir yöntemdir.

🔖

Cite This Article

ŞİRİN, O. D. S. (2019). Reflux Laryngıtıs: Dıagnosıs and Treatment. Klinik Tıp Aile Hekimliği, Cilt: 11 - Sayı: 2, 71–76. https://ajindex.com/articles/838031

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kaynaklar 1.Mungan Z. Prevalence and demographic determinants of gas-troesophageal reflux disease (GERD) in the Turkish generalpopulation: A population-based cross-sectional study Turk JGastroenterol 2012
  2. 23(4):323-332. 2.Koufman JA. The otolaryngologic manifestations of gastroesop-hageal reflux disease (GERD): a clinical investigation of 225 pa-tients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the deve-lopment of laryngeal injury. Laryngoscope 1991
  3. 101(53):1-78. 3.Hopkins C, Yousaf U, Pedersen M. Acid reflux treatment forhoarseness. The Cochrane Library 2006. 4.El-Serag HB. Time trends of gastroesophageal reflux disease: asystematic review. Clin Gastroenterol Hepatol 2007
  4. 17–26. 5.Altman KW, Stephen RM, Lyttle CS, Weiss KB. Changing im-pact of gastroesophageal reflux in medical and otolaryngo-logy practice. Laryngoscope 2005
  5. 115(7):1145-53. 6.Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R. The Mon-treal definition and classification of gastroesophageal refluxdisease: a global evidence-based consensus. Am J Gastroen-terol 2006
  6. 101(8):1900-20. 7.De Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M,Fattori B et al. How many cases of laryngopharyngeal ref-lux suspected by laryngoscopy are gastroesophageal reflux di-sease-related? World J Gastroenterol 2012
  7. 18(32):4363-70. 8.Johnson N, Bulmer D, Gill GA, Panetti M, Ross PE, PearsonJP et al. Cell biology of laryngeal epithelial defenses in he-alth and disease: further studies. Ann Otol Rhinol Laryngol2003
  8. 112(6):481-91. 9.Little FB, Koufman JA, Kohut RI, Marshall RB. Effect of gas-tric acid on the pathogenesis of subglottic stenosis. Ann OtolRhinol Laryngol 1985
  9. Belafsky PC, Postma GN, Koufman JA. Validity and reliabilityof the reflux symptom index (RSI). J Voice 2002
  10. 16(2):274-7. 11.Belafsky PC, Postma GN, Koufman JA. The validity and re-liability of the reflux finding score (RFS). Laryngoscope 2001
  11. 111(8):1313-7. 12.Powell J, Cocks HC. Mucosal changes in laryngopharynge-al reflux-prevalence, sensitivity, specificity and assessment.Laryngoscope 2013
  12. 123(4):985-91. 13.Hickson C, Simpson CB, Falcon R. Laryngeal pseudosulcusas a predictor of laryngopharyngeal reflux. Laryngoscope 2001
  13. Jette ME, Gaumnitz EA, Birchall MA, Welham NV, ThibeaultSL. Correlation between reflux and multichannel intralumi-nal impedance pH monitoring in untreated volunteers Laryn-goscope 2014
  14. 124(10):2345–51. 15.Miller FA, Do